USD 6.8 billion
Report ID:
SQMIG35A2420 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
89
|Figures:
76
Electrophysiology Devices Market size was valued at USD 6.8 billion in 2023 and is poised to grow from USD 7.44 billion in 2024 to USD 15.26 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
The growing use of electrophysiology (EP) tests in both the prevention and treatment of heart diseases such as atrial fibrillation, as well as the increased demand for equipment for cardiac rhythm leadership for continuous monitoring and the increasing application of these gadgets in out-of-hospital settings, are driving industry growth. Sedentary lifestyles, cigarette smoking, excessive alcohol use, and other factors are all contributing to an increase in the occurrence of heart failure, sudden cardiac arrest, and AF among millennials. According to the Centers for Disease Control and Prevention, roughly 12.1 million Americans will have AF by 2031.
Furthermore, Europeans are more susceptible to atrial fibrillation than African Americans. According to the European Society of Cardiology, one of the leading causes of death in Western countries is abrupt cardiac arrest caused by an irregular heart rhythm. Every year, around one in every 1,000 persons is affected. Cardiology specialist equipment used for the detection and management of heart arrhythmias is electrophysiology devices. As a result, the rising prevalence of heart disease is fueling market expansion. EP has made mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking more accessible. Remote monitoring of implanted cardiac devices, data storage in the public internet, and the addition of wireless transmission are projected to drive market expansion.
It enables healthcare providers to gain access to patient information, such as 3D photos and movies obtained during ablation treatments. Patients' preference for minimally invasive operations has grown in recent years. Cryoablation, laser therapy, ultrasonic ablation, and better mapping technologies are also anticipated to be beneficial to the sector. Medtronic, for example, got U.S. FDA approval in February 2022 for the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters for the management of Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients.
Market snapshot - 2025-2032
Global Market Size
USD 6.8 billion
Largest Segment
Inpatient
Fastest Growth
Outpatient
Growth Rate
9.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Electrophysiology Devices Market is segmented by Type, Indication, Application, End-user and region. Based on Type, the market is segmented into Ablation Catheters, Diagnostic Catheters, Mapping System, Accessories and Others. Based on Indication, the market is segmented into Atrial Fibrillation (AF), Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Supraventricular Tachycardia, Bradycardia, Wolff-Parkinson-White Syndrome (WPW) and Others. Based on Application, the market is segmented into Diagnostic Devices and Treatment Devices. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
With a 45.6% revenue share in 2023, the ablation catheters segment led the market and is predicted to increase at the quickest CAGR over the forecast period. When medicine is unable to treat an irregular heartbeat, an ablation catheter is utilised to regulate it. Cryoablation, pulse field ablation, and radiofrequency (RF) ablation are all included in the ablation catheter segment.
Over the course of the projection period, the diagnostic catheters segment is expected to grow at a high rate. Patients with suspected cardiovascular problems are investigated and assessed using diagnostic catheters. These include angiography catheters, cardiac output catheters, and EP mapping devices. Biosense Webster, Inc. introduced the OPTRELL mapping catheter in July 2023. A high-density diagnostic catheter called OPTRELL can map complicated cardiac rhythms in high definition using EP technology.
In 2023, the atrial fibrillation category dominated the market, accounting for more than 32.3% of total revenue. It is the most frequent type of arrhythmia, and it is linked to an increased risk of stroke and clotting of the blood. According to the British Heart Association, around 1.5 million people in the United Kingdom will have atrial fibrillation by 2022. Furthermore, an estimated 270,000 people (about half the population of Wyoming) aged 65 and up in the country have undetected atrial fibrillation. The high frequency of the condition accounts for the lion's share of the sector.
Innovative smartphone applications that connect arrhythmic patients with healthcare professionals have been created in recent years. Furthermore, hospitals and professional settings are taking steps to incorporate arrhythmia care into their treatment plans. During the forecast period, the Supraventricular Tachycardia (SVT) segment is expected to increase at a rate of 12.27%. Increased research to establish a therapy for SVT, rising medical expenses, and an increase in emergency admissions are all anticipated to favor sector expansion. SVT has a rate of 2.25 cases per 1,000 in the population, with a rate of 35 cases per 100,000 patients (about the seating capacity of the Los Angeles Memorial Coliseum), according to a study released by the National Library of Medicine.
In 2023, the inpatient facility segment held the largest share of revenue globally, accounting for 81.7% of total revenue. The leading proportion of the segment can be attributed to the increasing prevalence of cardiovascular disease (CVD) and interventional cardiologists' adoption of technologically improved cardiac rhythm management and EP systems. Given the availability of a highly qualified team of cardiologists and a state-of-the-art facility, it is anticipated that the number of procedures related to arrhythmias performed in inpatient facilities would rise in the upcoming years.
Over the forecast period, the outpatient facilities category is expected to increase at the quickest CAGR. Due to lower fixed expenses, it takes about 25% less time than inpatient facilities and saves between USD 360 and $1,000 per patient.
To get detailed analysis on other segments, Request For Free Sample Report
In 2023, the market for electrophysiology (EP) devices was dominated by North America, which had 48.3% of the global market share. The main factors driving this region's growth are the increased prevalence of cardiovascular disease, the sophisticated healthcare system, and the presence of important players. Furthermore, it is anticipated that the growing number of patients undergoing procedures and the increased public awareness of minimally invasive surgery will drive market expansion in North America.
The market for electrophysiology devices in Asia Pacific is anticipated to grow at the quickest rate of 14.8% over the course of the forecast period. Over the next ten years, the market is expected to rise due to factors such improving health awareness, the burgeoning private hospital sector, growing government expenditure and assistance, the rising prevalence of cardiovascular illnesses, and the expanding availability of insurance coverage.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence of Cardiac Arrhythmias
High Cost of Electrophysiology Devices
Request Free Customization of this report to help us to meet your business objectives.
The market is extremely competitive, with players pursuing new product development and large R&D investments as a long-term strategy. Companies around the world are pursuing an inorganic growth approach to expand product portfolios and gain a presence in the sector. For example, Boston Scientific Corp. finalized the acquisition of Baylis Medical firm Inc. in February 2022, a firm specializing in providing an advanced transseptal option for catheter-based treatments on the left side of the heart.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global electrophysiology devices market analysis, the growing use of electrophysiology (EP) tests in both the prevention and treatment of heart diseases such as atrial fibrillation, as well as the increased demand for equipment for cardiac rhythm leadership for continuous monitoring and the increasing application of these gadgets in out-of-hospital settings, are driving industry growth. Sedentary lifestyles, cigarette smoking, excessive alcohol use, and other factors are all contributing to an increase in the occurrence of heart failure, sudden cardiac arrest, and AF among millennials.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 6.8 billion |
Market size value in 2032 | USD 15.26 billion |
Growth Rate | 9.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Electrophysiology Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Electrophysiology Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Electrophysiology Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Electrophysiology Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Electrophysiology Devices Market size was valued at USD 8.94 Billion in 2023 and is poised to grow from USD 10.22 Billion in 2024 to USD 29.72 Billion by 2032, growing at a CAGR of 0.143 during the forecast period (2025-2032).
The market is extremely competitive, with players pursuing new product development and large R&D investments as a long-term strategy. Companies around the world are pursuing an inorganic growth approach to expand product portfolios and gain a presence in the sector. For example, Boston Scientific Corp. finalized the acquisition of Baylis Medical firm Inc. in February 2022, a firm specializing in providing an advanced transseptal option for catheter-based treatments on the left side of the heart. 'Medtronic (Ireland) ', 'Boston Scientific Corporation (US) ', 'Abbott (US) ', 'GE HealthCare (US) ', 'Biotronik SE & Co. KG (Germany) ', 'MicroPort Scientific Corporation (China) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Siemens Healthineers (Germany) ', 'CardioFocus Inc. (US) ', 'LivaNova PLC (UK) ', 'Penumbra, Inc. (US) ', 'Stereotaxis, Inc. (US) ', 'Advanced Cardiac Therapeutics, Inc. (US) ', 'CathRx Ltd. (Australia) ', 'Osypka Medical GmbH (Germany) ', 'AngioDynamics, Inc. (US) ', 'H2O.ai Inc. (US) ', 'DataRobot, Inc. (US) ', 'Clarifai, Inc. (US) ', 'Darktrace plc (UK) ', 'C3.ai, Inc. (US) '
Increasing Prevalence of Cardiac Arrhythmias
Minimally invasive procedures: There is a growing trend towards minimally invasive procedures in the field of electrophysiology. Advances in technology and device design have enabled the development of catheter-based techniques that allow for precise diagnosis and treatment of cardiac arrhythmias with reduced patient discomfort, shorter recovery times, and lower risk of complications.
In 2023, the market for electrophysiology (EP) devices was dominated by North America, which had 48.3% of the global market share. The main factors driving this region's growth are the increased prevalence of cardiovascular disease, the sophisticated healthcare system, and the presence of important players. Furthermore, it is anticipated that the growing number of patients undergoing procedures and the increased public awareness of minimally invasive surgery will drive market expansion in North America.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2420
[email protected]
USA +1 351-333-4748